ARKG 08/29/2023

ARK publishes a holdings file for each trading day that records how many shares each fund owns. The Shares Held column draws from these files: it displays today’s share count, and the number in parentheses shows the difference obtained by comparing today’s file with the previous trading day’s file.

#DateCompanyTickerCUSIPWeightShares HeldMarket Value
108/29/2023EXACT SCIENCES CORPEXAS30063P10510.50%2,624,195 (0) (0%)$210,276,745.35
208/29/2023PACIFIC BIOSCIENCES OF CALIFPACB69404D1085.67%11,458,926 (0) (0%)$113,672,545.92
308/29/2023SCHRODINGER INCSDGR80810D1035.49%3,072,456 (0) (0%)$110,055,373.92
408/29/2023IONIS PHARMACEUTICALS INCIONS4622221004.95%2,425,418 (0) (0%)$99,102,579.48
508/29/2023GINKGO BIOWORKS HOLDINGS INCDNA37611X1004.64%51,924,658 (0) (0%)$92,945,137.82
608/29/2023TELADOC HEALTH INCTDOC87918A1054.45%4,011,411 (0) (0%)$89,053,324.20
708/29/2023ACCOLADE INCACCD00437E1024.07%6,149,440 (6,149,440) $81,480,080.00
808/29/2023CRISPR THERAPEUTICS AGCRSPH171821083.90%1,565,299 (0) (0%)$78,202,338.04
908/29/2023INTELLIA THERAPEUTICS INCNTLA45826J1053.87%2,040,817 (8,701) (0.43%)$77,571,454.17
1008/29/2023ADAPTIVE BIOTECHNOLOGIESADPT00650F1093.63%11,796,206 (0) (0%)$72,782,591.02
1108/29/2023ARCTURUS THERAPEUTICS HOLDINARCT UQ03969T1093.07%1,949,583 (0) (0%)$61,489,847.82
1208/29/2023NVIDIA CORPNVDA67066G1043.05%130,268 (0) (0%)$61,011,017.80
1308/29/2023CAREDX INCCDNA14167L1033.03%6,847,861 (0) (0%)$60,672,048.46
1408/29/2023TWIST BIOSCIENCE CORPTWST90184D1002.89%2,937,555 (0) (0%)$57,928,584.60
1508/29/2023UIPATH INC – CLASS APATH90364P1052.80%3,725,645 (0) (0%)$56,182,726.60
1608/29/2023VERACYTE INCVCYT92337F1072.72%2,176,712 (0) (0%)$54,526,635.60
1708/29/2023RECURSION PHARMACEUTICALS-ARXRX75629V1042.72%6,333,695 (0) (0%)$54,533,113.95
1808/29/2023BEAM THERAPEUTICS INCBEAM07373V1052.61%2,231,138 (0) (0%)$52,275,563.34
1908/29/2023VERTEX PHARMACEUTICALS INCVRTX92532F1002.07%118,188 (0) (0%)$41,554,900.80
2008/29/2023VEEVA SYSTEMS INC-CLASS AVEEV9224751081.95%204,880 (0) (0%)$39,007,103.20
2108/29/2023VERVE THERAPEUTICS INCVERV92539P1011.91%2,939,654 (0) (0%)$38,186,105.46
2208/29/202310X GENOMICS INC-CLASS ATXG88025U1091.70%722,431 (0) (0%)$34,127,640.44
2308/29/2023INCYTE CORPINCY45337C1021.64%506,034 (0) (0%)$32,806,184.22
2408/29/2023QUANTUM-SI INCQSI74765K1051.62%14,731,296 (0) (0%)$32,408,851.20
2508/29/2023PRIME MEDICINE INCPRME74168J1011.56%2,374,817 (0) (0%)$31,228,843.55
2608/29/2023908 DEVICES INCMASS65443P1021.47%4,059,860 (0) (0%)$29,515,182.20
2708/29/2023MODERNA INCMRNA60770K1071.40%245,590 (0) (0%)$27,955,509.70
2808/29/2023REPARE THERAPEUTICS INCRPTX7602731021.35%2,686,371 (0) (0%)$27,132,347.10
2908/29/2023SOMALOGIC INCSLGC83444K1051.30%12,974,647 (0) (0%)$26,079,040.47
3008/29/2023REGENERON PHARMACEUTICALSREGN75886F1071.18%28,437 (0) (0%)$23,628,018.93
3108/29/2023COMPASS PATHWAYS PLCCMPS20451W1011.13%2,493,302 (0) (0%)$22,713,981.22
3208/29/2023GUARDANT HEALTH INCGH40131M1091.12%587,660 (0) (0%)$22,460,365.20
3308/29/2023BUTTERFLY NETWORK INCBFLY1241551021.09%13,031,159 (0) (0%)$21,762,035.53
3408/29/2023NURIX THERAPEUTICS INCNRIX67080M1030.99%2,310,854 (0) (0%)$19,919,561.48
3508/29/2023PFIZER INCPFE7170811030.86%475,744 (0) (0%)$17,226,690.24
3608/29/2023CERUS CORPCERS1570851010.59%6,450,859 (0) (0%)$11,805,071.97
3708/29/2023PERSONALIS INCPSNL71535D1060.44%5,862,371 (0) (0%)$8,852,180.21
3808/29/2023INVITAE CORPNVTA46185L1030.38%8,893,607 (0) (0%)$7,535,553.21
3908/29/2023GOLDMAN FS TRSY OBLIG INST 468X9USDGSFT0.12%2,331,437 (-2,109,311) (-47.5%)$2,331,437.13
4008/29/2023SENTI BIOSCIENCES INCSNTI81726A1000.06%1,863,562 (1,620,091) (665.41%)$1,169,944.22
4108/29/2023Senti Bio – place holdersharesDNBLFB2Y20.01%243,471 (243,471) $152,851.09
4208/29/2023PHENOMEX INCBLI0843101010.00%8,425 (8,425) $7,968.37
4308/29/2023CODEXIS INCCDXS1920051060.00%9,200 (-110,596) (-92.32%)$15,548.00
Source: https://assets.ark-funds.com/fund-documents/funds-etf-csv/ARK_GENOMIC_REVOLUTION_ETF_ARKG_HOLDINGS.csv

Discover more from ARK Invest Daily Trades Tracker

Subscribe to get the latest posts sent to your email.

Leave a Comment